Illegally stocked drugs worth Rs 5.21 lakh seized

HYDERABAD:  The Drugs Control Administration (DCA) raided the residence of a habitual offender in Moosarambagh, Malakpet, and seized spurious drugs worth Rs 5.21 lakh.

The accused, Puvvada Lakshmana, is a repeat offender previously involved in multiple spurious drug cases across the state. He had illegally stocked a large quantity of drugs at his home.

During the raid, four varieties of suspected spurious medicines were seized, including antidiabetics, antihypertensives, and abortion kits.

Acting on a tip-off, DCA officials raided the premises on Wednesday and recovered drugs such as Tazloc-CT 6.25 (Telmisartan and Chlorthalidone tablets), Dapacose-10 (Dapagliflozin tablets 10 mg), Dapacose-5 (Dapagliflozin tablets 5 mg), and Clear-Kit (combipack of Mifepristone and Misoprostol tablets).

Samples have been sent for analysis. Officials confirmed that further investigation is underway, and legal action will be taken against all those involved.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs